Brian Dalke, Fourth-Year Pharmacy Student Timothy Ivers, Fourth-Year Pharmacy Student Karen K. O’Brien, BS Pharm, Pharm D, RPh Assistant Professor of Pharmacy Sciences Shana Castillo, Pharm D, MBA, RPh Assistant Professor of Pharmacy Practice Eric Hoie, Pharm D, RPh Associate Professor of Pharmacy Practice Kimberley Begley, Pharm D, RPh Associate Professor of Pharmacy Practice Creighton University School of Pharmacy & Health Professions Omaha, Nebraska US Pharm. ABSTRACT: Gonorrhea is the second most common communicable disease in the United States. From 2010 to 2014, the rate of this sexually transmitted disease increased by 10.5% in the U. Cefixime, which was once the first-line agent for the treatment of Neisseria gonorrhoeae, is rapidly waning in efficacy, as are several other cephalosporins. Similarly, fluoroquinolone-resistant strains of N gonorrhoeae have been reported. As a result, the use of these agents has decreased. The CDC currently recommends dual treatment with ceftriaxone and azithromycin for most gonococcal infections. Multidrug-resistant gonorrhea is becoming a serious health threat in the U. Neisseria gonorrhoeae is the second most common communicable disease in the United States, behind Chlamydia trachomatis. (Health Day)—When an unnamed British man recently contracted a form of "super gonorrhea" resistant to the antibiotics commonly used to treat it, the news spiked concern in doctors and microbiologists worldwide. This week, physicians did cure the man's sexually transmitted disease using an antibiotic called ertapenem, but they called the case a "major wake-up call for everybody." One way to slow gonorrhea's progression to total antibiotic resistance is to stick to the recommended treatment regimen. But new data released Thursday finds that just isn't being done in 1 out of every 5 gonorrhea cases in the United States. In 19 percent of cases reviewed, patients did not receive the dual ceftriaxone-azithromycin antibiotic therapy that's recommended by the U. Centers for Disease Control and Prevention, agency researchers reported. In most gonorrhea cases, patients "should be treated with the recommended regimen to ensure effective treatment and to help forestall the emergence of antimicrobial resistance," said a team led by Emily Weston, an STD researcher at the CDC. According to the agency, nearly 470,000 cases of gonorrhea were reported in the United States in 2016, up 18.5 percent from the year before. What's more, the bacterium "has progressively developed resistance to most antimicrobials," Weston and her colleagues said.
Feb 6, 2018. Gonorrhea is a common infection that often causes no signs or. with either azithromycin Zithromax, Zmax or doxycycline Monodox. Fills you in on the topic, does doxycycline treat both chlamydia and gonorrhea, with a wealth of fact sheets, expert advice, community perspective.